BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DNA fingerprint
,
Lipopolysaccharide
,
rs2300478
,
PPARA
,
Fatty acid metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
oligodendrocyte development
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Spinal cord
Corpus callosum
Nodose nucleus
Subthalamic nucleus
Ventral tegmental area
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Leukoencephalopathy
Vesicular stomatitis Indiana virus disease
Pyloric ulcer
Varicella-zoster virus infection
Alpha-1-antitrypsin deficiency
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
CGP 60474
flavopiridol
A 443654
AT 7519
BMS 387032
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SMN2
NCL
MTTP
NR5A1
CCNB1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
L1000 CMAP - Prostate cancer PC3.101 cells with CRISPR-targeted gene knockouts
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Sema4D as an inhibitory regulator in oligodendrocyte development.
The identification of transcriptional targets of Ascl1 in oligodendrocyte development.
In vivo analysis of kallikrein-related peptidase 6 (KLK6) function in oligodendrocyte development an…
Common mechanism underlying oligodendrocyte development and oligodendrogliomagenesis].
Tyrosine phosphatases Shp1 and Shp2 have unique and opposing roles in oligodendrocyte development.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Oligodendrocyte Progenitor Cell Culture From Human Brain
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oli…
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in …
rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease
Brain White Matter Injury in Late Preterm Infants
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ